Advances in Multiple Sclerosis Research-Series I
Designing immunotherapeutics, drugs, and anti-inflammatory reagents has been at the forefront of autoimmune research, in particular multiple sclerosis, for over 20 years. Delivery methods that are used to modulate effective and long-lasting immune responses have been the major focus. This Special Is...
Saved in:
| HerausgeberIn: | |
|---|---|
| Sonstige: | |
| Year of Publication: | 2021 |
| Language: | English |
| Physical Description: | 1 electronic resource (334 p.) |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| id |
993545117504498 |
|---|---|
| ctrlnum |
(CKB)5400000000042045 (oapen)https://directory.doabooks.org/handle/20.500.12854/68583 (EXLCZ)995400000000042045 |
| collection |
bib_alma |
| record_format |
marc |
| spelling |
Matsoukas, John edt Advances in Multiple Sclerosis Research-Series I Basel, Switzerland MDPI - Multidisciplinary Digital Publishing Institute 2021 1 electronic resource (334 p.) text txt rdacontent computer c rdamedia online resource cr rdacarrier Open access Unrestricted online access star Designing immunotherapeutics, drugs, and anti-inflammatory reagents has been at the forefront of autoimmune research, in particular multiple sclerosis, for over 20 years. Delivery methods that are used to modulate effective and long-lasting immune responses have been the major focus. This Special Issue focused on delivery methods to be used for vaccines, immunotherapeutic approaches, drug design, and anti-inflammatories and their outcomes in preclinical studies and clinical trials. English Medicine bicssc multiple sclerosis inflammation oxidative biomarker sample size autoimmune encephalitis plasma exchange autoimmunity immunotherapeutics clinical outcomes major depression bupropion S-adenosylmethionine vitamin D3 yoga craniopharyngioma fractionated stereotactic radiation treatments sphenoid sinusitis cranial nerve-VI palsy autoimmune diseases immune thrombocytopenic purpura alemtuzumab antibodies against GluR3 peptide cognitive impairment diagnosis neuropsychological assessment short intracortical inhibition intracortical facilitation fampridine walking disability TSPAN32 tetraspanins cellular immunity memory T cells tDCS neuroimaging positron emission tomography cerebral blood flow probiotics Streptococcus thermophilus ST285 MBP83–99 peptide mannan immune modulation agonist peptide gut microbiome gut–brain axis metagenomics disease-modifying treatments MS vaccine immunomodulation carriers B cell receptor delivery methods immunotherapy monoclonal antibodies T cell receptor tolerance diagnostic markers immunoglobulins kappa free light chains antigen-specific immunotherapies tolerogenic vaccines tolerance induction central nervous system myelin peptides myelin basic protei proteolipid protein myelin oligodendrocyte glycoprotein nanotechnology drug delivery nanosystems lipids polymers vaccines nanoparticles antigen-specific immunotherapy experimental autoimmune encephalomyelitis neurodegeneration chloroquine EAE dendritic cells microglia astrocytes oligodendrocytes conformational analysis peptides altered peptide ligands NMR spectroscopy NOE-constraints molecular dynamic trimolecular complex Multiple Sclerosis early-onset adult-onset Human Leucocyte Antigens immunogenetics clinical phenotype clinical outcome therapeutics antibody detection ELISA multivalency N-glucosylated peptide epitopes peptide conjugation MOG35-55 Graphite/SiO2 electrode voltammetry HPLC MS drugs 3-03943-947-2 3-03943-948-0 Apostolopoulos, Vasso edt Matsoukas, John oth Apostolopoulos, Vasso oth |
| language |
English |
| format |
eBook |
| author2 |
Apostolopoulos, Vasso Matsoukas, John Apostolopoulos, Vasso |
| author_facet |
Apostolopoulos, Vasso Matsoukas, John Apostolopoulos, Vasso |
| author2_variant |
j m jm v a va |
| author2_role |
HerausgeberIn Sonstige Sonstige |
| title |
Advances in Multiple Sclerosis Research-Series I |
| spellingShingle |
Advances in Multiple Sclerosis Research-Series I |
| title_full |
Advances in Multiple Sclerosis Research-Series I |
| title_fullStr |
Advances in Multiple Sclerosis Research-Series I |
| title_full_unstemmed |
Advances in Multiple Sclerosis Research-Series I |
| title_auth |
Advances in Multiple Sclerosis Research-Series I |
| title_new |
Advances in Multiple Sclerosis Research-Series I |
| title_sort |
advances in multiple sclerosis research-series i |
| publisher |
MDPI - Multidisciplinary Digital Publishing Institute |
| publishDate |
2021 |
| physical |
1 electronic resource (334 p.) |
| isbn |
3-03943-947-2 3-03943-948-0 |
| illustrated |
Not Illustrated |
| work_keys_str_mv |
AT matsoukasjohn advancesinmultiplesclerosisresearchseriesi AT apostolopoulosvasso advancesinmultiplesclerosisresearchseriesi |
| status_str |
n |
| ids_txt_mv |
(CKB)5400000000042045 (oapen)https://directory.doabooks.org/handle/20.500.12854/68583 (EXLCZ)995400000000042045 |
| carrierType_str_mv |
cr |
| is_hierarchy_title |
Advances in Multiple Sclerosis Research-Series I |
| author2_original_writing_str_mv |
noLinkedField noLinkedField noLinkedField |
| _version_ |
1787548505448906752 |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>05233nam-a2201669z--4500</leader><controlfield tag="001">993545117504498</controlfield><controlfield tag="005">20231214132850.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr|mn|---annan</controlfield><controlfield tag="008">202105s2021 xx |||||o ||| 0|eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)5400000000042045</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/68583</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)995400000000042045</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Matsoukas, John</subfield><subfield code="4">edt</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Advances in Multiple Sclerosis Research-Series I</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="a">Basel, Switzerland</subfield><subfield code="b">MDPI - Multidisciplinary Digital Publishing Institute</subfield><subfield code="c">2021</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 electronic resource (334 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="506" ind1=" " ind2=" "><subfield code="a">Open access</subfield><subfield code="f">Unrestricted online access</subfield><subfield code="2">star</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Designing immunotherapeutics, drugs, and anti-inflammatory reagents has been at the forefront of autoimmune research, in particular multiple sclerosis, for over 20 years. Delivery methods that are used to modulate effective and long-lasting immune responses have been the major focus. This Special Issue focused on delivery methods to be used for vaccines, immunotherapeutic approaches, drug design, and anti-inflammatories and their outcomes in preclinical studies and clinical trials.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Medicine</subfield><subfield code="2">bicssc</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">multiple sclerosis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">inflammation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">oxidative</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">biomarker</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">sample size</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">autoimmune encephalitis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">plasma exchange</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">autoimmunity</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">immunotherapeutics</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">clinical outcomes</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">major depression</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">bupropion</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">S-adenosylmethionine</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">vitamin D3</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">yoga</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">craniopharyngioma</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">fractionated stereotactic radiation treatments</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">sphenoid sinusitis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cranial nerve-VI palsy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">autoimmune diseases</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">immune thrombocytopenic purpura</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">alemtuzumab</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">antibodies against GluR3 peptide</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cognitive impairment</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">diagnosis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">neuropsychological assessment</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">short intracortical inhibition</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">intracortical facilitation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">fampridine</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">walking disability</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">TSPAN32</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">tetraspanins</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cellular immunity</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">memory T cells</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">tDCS</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">neuroimaging</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">positron emission tomography</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cerebral blood flow</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">probiotics</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Streptococcus thermophilus</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">ST285</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">MBP83–99 peptide</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">mannan</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">immune modulation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">agonist peptide</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">gut microbiome</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">gut–brain axis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">metagenomics</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">disease-modifying treatments</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">MS</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">vaccine</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">immunomodulation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">carriers</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">B cell receptor</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">delivery methods</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">immunotherapy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">monoclonal antibodies</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">T cell receptor</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">tolerance</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">diagnostic markers</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">immunoglobulins</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">kappa</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">free light chains</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">antigen-specific immunotherapies</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">tolerogenic vaccines</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">tolerance induction</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">central nervous system</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">myelin peptides</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">myelin basic protei</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">proteolipid protein</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">myelin oligodendrocyte glycoprotein</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">nanotechnology</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">drug delivery nanosystems</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">lipids</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">polymers</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">vaccines</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">nanoparticles</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">antigen-specific immunotherapy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">experimental autoimmune encephalomyelitis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">neurodegeneration</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">chloroquine</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">EAE</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">dendritic cells</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">microglia</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">astrocytes</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">oligodendrocytes</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">conformational analysis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">peptides</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">altered peptide ligands</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">NMR spectroscopy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">NOE-constraints</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">molecular dynamic</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">trimolecular complex</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Multiple Sclerosis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">early-onset</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">adult-onset</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Human Leucocyte Antigens</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">immunogenetics</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">clinical phenotype</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">clinical outcome</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">therapeutics</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">antibody detection</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">ELISA</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">multivalency</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">N-glucosylated peptide epitopes</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">peptide</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">conjugation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">MOG35-55</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Graphite/SiO2 electrode</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">voltammetry</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">HPLC</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">MS drugs</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-03943-947-2</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-03943-948-0</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Apostolopoulos, Vasso</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Matsoukas, John</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Apostolopoulos, Vasso</subfield><subfield code="4">oth</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-12-15 05:34:47 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2022-04-04 09:22:53 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5337907770004498&Force_direct=true</subfield><subfield code="Z">5337907770004498</subfield><subfield code="b">Available</subfield><subfield code="8">5337907770004498</subfield></datafield></record></collection> |